基于多变量信息融合和图形对比学习来预测药物目标相互作用
Siying Yang1, Ping-An He1, Pan Zeng2
1School of Science, Zhejiang Sci-Tech University, Hangzhou, 310018, ZheJiang, China.
Journal of biomedical informatics
|November 19, 2025
概括
这项研究介绍了MGCLDTI,这是一种用于预测药物向相互作用 (DTI) 的新型机器学习模型. 它通过整合多视图信息和采用图形对比学习 (GCL) 来克服数据稀疏性挑战,提高了预测准确性.
科学领域:
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
- 机器学习 机器学习
背景情况:
- 传统的药物向相互作用 (DTI) 预测方法缓慢而昂贵.
- 机器学习提供了一个更快的替代方案,但数据稀疏性和节点表示不足阻碍了准确性.
- 现有的方法在整合节点信息时往往忽视了拓上的相似性.
研究的目的:
- 开发一个先进的模型,MGCLDTI,用于准确的DTI预测.
- 为了应对数据稀疏性和DTI预测中不充分的节点嵌入的挑战.
- 利用多视图信息和图形对比学习来改进DTI识别.
主要方法:
- 使用DeepWalk从异质图 (药物,目标,疾病) 中提取全球拓表示.
- 实施了密集化策略,以减轻稀疏DTI矩阵产生的噪声.
- 应用了一个带有节点掩盖的图形对比学习 (GCL) 模型,以增强本地意识和优化嵌入.
- 使用LightGBM算法进行最终的DTI得分预测.
主要成果:
- 与最先进的方法相比,MGCLDTI表现出优越的预测性能.
- 废弃性研究证实了每个模型组件的显著贡献.
- 案例研究验证了MGCLDTI在识别潜在药物向相互作用方面的准确性.
结论:
- 通过整合多视图数据和采用先进的图形学习技术,MGCLDTI有效地预测药物向相互作用.
- 该模型成功地解决了数据稀疏性,并增强了节点表示学习,以改进DTI预测.
- MGCLDTI显示出加速药物发现和医学研究的巨大潜力.
相关概念视频
Agonism and Antagonism: Quantification
952
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
952
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Quantitative Aspects of Drug-Receptor Interaction
1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Drug-Receptor Interactions
7.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.2K
Combined Effects of Drugs: Antagonism
11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K


